GODAVARI DRU Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU Quarterly Results    (GDVD)

Here are the latest quarterly results of GODAVARI DRU. For more details, see the GODAVARI DRU financial fact sheet and GODAVARI DRU share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GODAVARI DRU Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m223231259244257309331330 
Other income Rs m10020211 
Turnover Rs m224231259247257311332331 
Expenses Rs m207217241231234285305304 
Gross profit Rs m1514181323242626 
Depreciation Rs m33333334 
Interest Rs m77788888 
Profit before tax Rs m648411151515 
Tax Rs m222-33552 
Profit after tax Rs m43589101013 
Gross profit margin %6.96.16.85.48.87.87.87.8 
Effective tax rate %32.337.730.7-74.826.034.835.114.0 
Net profit margin %1.91.22.13.13.33.23.03.9 
Diluted EPS Rs 0.6 0.4 0.7 1.0 1.1 1.3 1.3 1.7  
Diluted EPS (TTM) Rs NA NA 2.1 2.7 3.2 4.2 4.8 5.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   ALKEM LABORATORIES  WANBURY  RELISH PHARMA  BERYL DRUGS  TEJNAKSH HEALTHCARE  

Compare GODAVARI DRU With:   ALKEM LABORATORIES  WANBURY  RELISH PHARMA  BERYL DRUGS  TEJNAKSH HEALTHCARE  



Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GODAVARI DRU SHARE PRICE


Jul 30, 2021 (Close)

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GODAVARI DRU

GODAVARI DRU 5-YR ANALYSIS

COMPARE GODAVARI DRU WITH

MARKET STATS